|
|
Embracing a new horizon in psoriasis management
|
Thursday 10 October 2019
17:00–18:30
|
|
|
Chair: Richard Langley
Dalhousie University
& Nova Scotia Health
Authority, Canada |
|
|
|
Wolf-Henning Boehncke
University of Geneva,
Switzerland |
|
|
|
Jo Lambert
Ghent University,
Belgium |
|
| IL-23 inhibitors: taking us into a new horizon in psoriasis care |
| A new horizon – how did we get here? |
Bringing innovation into your daily practice |
| The future is now: bringing patients a life not impacted by psoriasis |
|
|
|
|
|
New horizons: Emerging possibilities
in the management of
atopic dermatitis
|
Friday 11 October 2019
17:00–18:30
|
|
|
Chair: Kristian Reich
University Clinic
Hamburg-Eppendorf &
Skinflammation®, Germany |
|
|
|
Alan Irvine
Trinity College Dublin,
Ireland |
|
|
|
Emma Guttman-Yassky
Mount Sinai
Medical Center, USA |
|
| Current therapy for AD – evolving landscape and remaining unmet needs |
| Pathogenesis of AD – potential to advance the standard of care |
| Translating scientific knowledge into clinical data – expanding possibilities in AD treatment |
|
|
|